Jieyu Zou, is a Principal with Lilly Asia Ventures (LAV). Prior to joining LAV, she was an investment manager in Fosun healthcare group. Prior to that, she worked as a research associate in Michael Allen Company, providing consulting service to clients from leading pharmaceutical companies. Jieyu holds a M.P.H. degree from Yale University School of Public Health and her dual bachelor’s in Biology and Psychology from Peking University.